ViraDx SARS-CoV-2/Flu A+B Rapid Antigen Test
$349.95
SKU CP0031
ViraDx SARS-CoV-2/Flu A+B Rapid Antigen Test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and influenza B directly from anterior nasal or nasopharyngeal swab specimens obtained from patients who are suspected of COVID-19 by their healthcare provider, within the first five days of onset of symptoms.
Product Specifications
| Tests/Box | 25 |
| Sample type | Nasopharyngeal or Anterior Nasal Swab |
| Time to results | 15 minutes |
| COVID-19 | 93.8% Sensitivity / 100% Specificity |
| Flu A | 92.2% Sensitivity / 94.2% Specificity |
| Flu B | 90.0% Sensitivity / 94.3% Specificity |
| Kit contents | (25) Test Devices, (25) Extraction Reagent in Capsules, (25) Sterile Swabs, (1) Positive Control Swab, (1) Negative Control Swab, Package Insert |
| Storage | 35-86°F (2-30°C) |
| CLIA complexity | Waived |
| Certification | FDA EUA |
CPT Codes
- COVID-19: 87811QW
- Flu A: 87804QW
- Flu B: 87804QW-59
More Information
- EUA2202314/S012